Except as permitted in §37.54 of this title (relating to Exemption from Screens), all newborns delivered in Texas shall receive two screens for the following disorders:

1. (1) galactose-1-phosphate uridyltransferase deficiency;
2. (2) sickling hemoglobinopathies;
3. (3) 21-hydroxylase deficiency;
4. (4) hypothyroidism;
5. (5) amino acid disorders, including argininosuccinic acidemia, citrullinemia, homocystinuria, maple syrup urine disease, phenylketonuria, and tyrosinemia type I;
6. (6) fatty acid oxidation disorders, including carnitine uptake defect, long-chain hydroxyacyl-CoA dehydrogenase deficiency, medium-chain acyl-CoA dehydrogenase deficiency, trifunctional protein deficiency, and very-long-chain acyl-CoA dehydrogenase deficiency;
7. (7) organic acidemias, including 3-methylcrotonyl-CoA carboxylase deficiency, beta-ketothiolase deficiency, glutaric acidemia type I, hydroxymethylglutaric aciduria, isovaleric acidemia, methylmalonic acidemia (Cbl A and Cbl B forms), methylmalonic acidemia (mutase deficiency form), multiple carboxylase deficiency, and propionic acidemia; and
8. (8) biotinidase deficiency.

Source Note:The provisions of this §37.53 adopted to be effective November 1, 2006, 31 TexReg 8835.